|
Adverse events reported during the study |
|||
| Body system |
Normal/mild |
Moderate/severe |
Total |
|
|
|||
| Any event |
2 (20%) |
11 (37%)* |
13 (33%) |
| Cardiovascular |
|||
| Any event |
0 |
4 (13%) |
4 (10%) |
| Cardiac arrest |
0 |
2 (7%) |
2 (5%) |
| Sinus arrest |
0 |
1 (3%) |
1 (3%) |
| Ventricular fibrillation |
0 |
1 (3%) |
1 (3%) |
| Digestive |
|||
| Any event |
1 (10%) |
3 (10%) |
4 (10%) |
| Diarrhoea |
1 (10%) |
1 (3%) |
2 (5%) |
| Ileus |
0 |
2 (7%) |
2 (5%) |
| Ischaemic bowel |
0 |
1 (3%) |
1 (3%) |
| Body as a whole |
|||
| Any event |
0 |
3 (10%) |
3 (8%) |
| Multiple organ failure |
0 |
2 (7%) |
2 (5%) |
| Sepsis |
0 |
1 (3%) |
1 (3%) |
| Musculoskeletal |
|||
| Any event |
0 |
2 (7%) |
2 (5%) |
| Muscle rigidity |
0 |
2 (7%) |
2 (5%) |
| Nervous |
|||
| Any event |
1 (10%) |
1 (3%) |
2 (5%) |
| Agitation |
1 (10%) |
1 (3%) |
2 (5%) |
|
*P = 0.451 versus normal/mild group (Fisher's exact test). | |||
Breen et al. Critical Care 2004 8:R21 doi:10.1186/cc2399 |
|||